COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they should consider when reviewing requests by physicians and others for individual patient access to investigational drugs.
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten it, according to a new study published in the Centers for Disease Control and Prevention’s Emerging Infectious Diseases Journal.
The Centers for Medicare & Medicaid Services recently issued new guidance implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group, established by the Families First Coronavirus Response Act.
CMS Issued New Guidance for States on the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group
The Centers for Medicare & Medicaid Services (CMS) released guidance on June 2 for states implementing the Medicaid Optional Uninsured COVID-19 Testing (XXIII) Group, established by the Families First Coronavirus Response Act.
The Food and Drug Administration recently created an online compendium page of COVID-19 resources for health care professionals.
The Food and Drug Administration authorized the emergency use of two new products designed to respond to the COVID-19 ventilator shortage.
The Center for Medicare and Medicaid Innovation (CMMI) today announced several COVID-19 related modifications to current and future CMMI alternative payment models (APMs). The adjustments are captured in a summary table and are related to the models’ financial methodologies, quality reporting…
The Centers for Disease Control and Prevention updated its page on COVID-19 transmission to clarify other types of spread beyond person to person, such as by someone touching a surface that has the virus on it and then touching their own face.
The Food and Drug Administration updated guidance to spur wider availability of alcohol-based hand sanitizers during the COVID-19 pandemic.
The Centers for Medicare & Medicaid Services implemented several new infection control actions to combat COVID-19 in nursing homes.